Economic Evaluation of Positron Emission Tomography (PET) in Non Small Cell Lung Cancer (NSCLC), CHERE Working Paper 2007/6



However, unlike the CT negative results we see the ICER for CT positive patients
increase as the rate of upstaging is increased. This is because slightly more upstaging occurs in
the PET strategy than the CWU strategy with 0.525 patients being upstaged compared to 0.43
due to false negatives in PET proceeding straight to surgery without a mediastinoscopy.
Therefore, we see the PET versus the CWU strategy becoming less cost effective with the
ICER increasing to $A 55,827 when the rate of upstaging is increased and falling to $A 50,144
when the rate of upstaging is decreased. These results may radically change if QALY
assumptions are introduced.

Radiotherapy and chemotherapy costs

There was much uncertainty about the chemotherapy and radiotherapy costs in the
model as there is no certain Australia data on costs of these treatments in NSCLC. Therefore, a
two way sensitivity analyses was carried out to take account of this uncertainty and can be seen
in table 13 for CT negative patients and

Table 13: Two way sensitivity analysis of the cost of chemotherapy and radiotherapy in
CT negative patients

Chemotherapy Costs

Radiotherapy Costs

4000

6000

8000

9,784

10000

12000

14000

6000

696.1

1373.1

2050.1

2653.9

2727.0

3404.0

4081.0

8000

3707.2

4384.2

5061.2

5665.0

5738.1

6415.1

7092.1

10000

6718.3

7395.3

8072.3

8676.1

8749.2

9426.2

10103.2

12000

9729.4

10406.4

11083.4

11687.2

11760.3

12437.3

13114.3

13922

12623.1

________4_

13300.1

13977.0

14580.9

________5_

14654.0

15331.0

16008.0

14000

12740.5

13417.5

14094.5

14698.3

14771.4

15448.4

16125.4

16000

15751.6

16428.6

17105.6

17709.4

17782.6

18459.5

19136.5

18000

18762.7

19439.7

20116.7

20720.5

20793.7

21470.6

22147.6

20000

21773.8

22450.8

23127.8

23731.6

23804.8

24481.7

25158.7

The results show that in the CT negative patients that as the costs of radiotherapy and
chemotherapy increase the ICERs is also increases. This reflects that PET correctly stages
more patients with N2/3 for joint chemotherapy and radiotherapy and identifies more patients
with M1 disease than the CWU strategy. However, the ICERs for the CT negative patients do
not change greatly considering the large movements in the costs and never become excessively
high.

23



More intriguing information

1. Langfristige Wachstumsaussichten der ukrainischen Wirtschaft : Potenziale und Barrieren
2. The name is absent
3. Self-Help Groups and Income Generation in the Informal Settlements of Nairobi
4. Firm Creation, Firm Evolution and Clusters in Chile’s Dynamic Wine Sector: Evidence from the Colchagua and Casablanca Regions
5. EFFICIENCY LOSS AND TRADABLE PERMITS
6. An Efficient Circulant MIMO Equalizer for CDMA Downlink: Algorithm and VLSI Architecture
7. Family, social security and social insurance: General remarks and the present discussion in Germany as a case study
8. A Pure Test for the Elasticity of Yield Spreads
9. The name is absent
10. Tourism in Rural Areas and Regional Development Planning